All In Biotech

Drug Trial Radar · NCT05619926

Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor

A Multi-center, Open-label, Multiple-dose Design, Phase 2 Trial to Evaluate the Safety and Efficacy of STSP-0601 for Injection in Patients With Hemophilia Without Inhibitor

Last checked: Nov 19, 2026Latest source record: Jan 2, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

32

Actual

Start

Jan 9, 2023

Primary completion

Aug 25, 2023

Study completion Aug 25, 2023

Sponsor

Sponsor type
Industry
Collaborators
Beijing Novikang Medical Technology Co., LTD
First posted
Nov 17, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Male only, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will assess the safety,efficacy,pharmacokinetics and pharmacodynamics of multiple-dose of STSP-0601 at two dose levels for the treatment of bleeding episodes in hemophilia A or B patients without inhibitor.

Conditions

  • Hemophilia

Interventions

  • STSP-0601 for InjectionDrug

    Intravenous Injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of adverse eventsTime frame: From day 0 to up to day 4
  2. Proportion of successfully treated bleeding episodesTime frame: 8 hours after first administration of study drug

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • The Second Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China

  • Lanzhou University First Hospita

    Lanzhou, Gansu, China

  • Shenzhen Second People's Hospital

    Shenzhen, Guangdong, China

  • North China University of Technology Affiliated Hospital

    Tangshan, Hebei, China

  • The First Affiliated Hospital of Nanyang Medical College

    Nanyang, Henan, China

  • Henan Cancer Hospital

    Zhengzhou, Henan, China

  • Xiangya Hospital of Central South University

    Changsha, Hunan, China

  • Nanjing Gulou Hospital

    Nanjing, Jiangsu, China

  • The First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China

  • Xi'an Central Hospital

    Xi’an, Shanxi, China

  • Hospital of Hematology, Chinese Academy of Medical Sciences

    Tianjin, Tianjin Municipality, China

  • The Second Affiliated Hospital of Kunming Medical University

    Kunming, Yunnan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.